by Rod Raynovich | Jul 23, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Good financials have perked up interest is mid-cap Diagnostics companies that released results today. Immucor (BLUD) a global leader in automated analysis of blood transfusion systems had revenue of $82.9M up 5% from prior year quarter with diluted earnings of $0.30...